Novel heterozygous variants in the EP300 gene cause Rubinstein–Taybi syndrome 2: Reports from two Chinese children
Open Access
- 10 May 2023
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (9) , e2192
Abstract
Background: Rubinstein–Taybi syndrome (RSTS) is a rare autosomal‐dominant genetic disease caused by variants of CREBBP (RSTS1) or EP300 (RSTS2) gene. RSTS2 is much less common, with less than 200 reported cases worldwide to date. More reports are still needed to increase the understanding of its clinical manifestations and genetic characteristics.Methods: The clinical data of two children with RSTS2 were analyzed retrospectively, and their clinical manifestations, auxiliary examinations, and mutational spectrum were summarized. Liquid chromatography–tandem mass spectrometer (LC–MS/MS) technology was used to detect the levels of steroid hormones if possible.Results: After analyzing the clinical and genetic characteristics of two boys with RSTS2 (0.7 and 10.4 years old, respectively) admitted in our hospital, we identified two novel heterozygous variants in the EP300 exon 22 (c.3750C > A, p. Cys1250*, pathogenic; c.1889A > G, p. Tyr630Cys, likely pathogenic), which could account for their phenotype. In addition to common clinical manifestations such as special facial features, microcephaly, growth retardation, intellectual disability, speech delay, congenital heart defect, recurrent respiratory infections, and immunodeficiency, we found one of them had a rare feature of adrenal insufficiency, and LC–MS/MS detection showed an overall decrease in steroid hormones.Conclusion: In our study, we identified two novel variants in the EP300 exon 22, and for the first time, we reported a case of RSTS2 associated with adrenal insufficiency, which will enrich the clinical and mutational spectrum of this syndrome.Keywords
This publication has 17 references indexed in Scilit:
- Ultra-Rare Syndromes: The Example of Rubinstein–Taybi SyndromeJournal of Pediatric Genetics, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and managementItalian Journal of Pediatrics, 2015
- Genetic Interaction between Mutations in c-Myb and the KIX Domains of CBP and p300 Affects Multiple Blood Cell Lineages and Influences Both Gene Activation and RepressionPLOS ONE, 2013
- Confirmation of EP300 gene mutations as a rare cause of Rubinstein–Taybi syndromeEuropean Journal of Human Genetics, 2007
- SF-1 (Nuclear Receptor 5A1) Activity Is Activated by Cyclic AMP via p300-Mediated Recruitment to Active Foci, Acetylation, and Increased DNA BindingMolecular and Cellular Biology, 2005
- Involvement of multiple transcription factors in the regulation of steroidogenic acute regulatory protein gene expressionSteroids, 2003
- Steroidogenic Factor 1: A Key Determinant of Endocrine Development and FunctionEndocrine Reviews, 1997
- Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBPNature, 1995
- Broad Thumbs and Toes and Facial AbnormalitiesAmerican Journal of Diseases of Children, 1963